Founded in 2010, Celnovte Biotechnology is headquartered in Zhengzhou, China, focusing on reagent and instrument development and manufacturing. Our subsidiaries include Shenzhen for instrument R&D, Suzhou for research-use product development, and Maryland (USA) for reagent R&D. Our advanced medical instrument manufacturing facilities span 3,000m² in Shenzhen and 10,000m² in Zhengzhou. We also operate a GMP-certified lab equipped with state-of-the-art research, production, and quality inspection instruments.
Celnovte leads the industry with its fully automated pathology instruments, including IHC stainers, H&E stainers, special stainers, cytopathology instrumentation, and digital slide scanners. Since launching in 2018, we’ve successfully installed over 700 fully automated IHC stainers globally. Our extensive domestic and international network covers over 2,300 top hospitals in China and extends to more than 40 countries worldwide.
Celnovte adheres to international quality control standards, including ISO9001 and ISO13485. Our products are CE-IVD certified, and we are actively pursuing FDA certification to further expand our global market presence.
Interested in becoming a Celnovte distributor? Join us for an opportunity to gain pricing advantages, regional protection, strategic partnerships, regular training, and full technical and branding support. Contact us to learn more about our distributor program.
Looking to develop OEM or ODM solutions with Celnovte? Our collaborative planning approach and over 10 years of pathology instrument design experience ensure we deliver customized, fully integrated solutions that meet your needs. From pre-sales consultations to post-sales support, we provide comprehensive, one-on-one service to bring your ideas to life.
Celnovte is rapidly expanding internationally, and we invite you to join us in growing together. Contact us now to explore partnership opportunities and learn how we can collaborate for mutual success.